Article Details

Landos Biopharma Announces Positive Results from a Phase 1 Study of NX-13 in Healthy ...

Retrieved on: 2021-03-04 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Landos Biopharma Announces Positive Results from a Phase 1 Study of NX-13 in Healthy .... View article details on hiswai:

Excerpt

BLACKSBURG, Va., March 04, 2021 (GLOBE NEWSWIRE) -- Landos Biopharma (NASDAQ: LABP), a clinical-stage biopharmaceutical company ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up